These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2905690)

  • 21. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ulcer disease: as seen today].
    Varró V
    Orv Hetil; 1988 May; 129(18):919-23. PubMed ID: 2898743
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recurrence factors of peptic ulcers and their prevention].
    Ogoshi K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):37-40. PubMed ID: 1673703
    [No Abstract]   [Full Text] [Related]  

  • 24. Abdominal and dyspeptic symptoms in patients with peptic ulcer treated medically or surgically.
    Lindsetmo RO; Johnsen R; Revhaug A
    Br J Surg; 1998 Jun; 85(6):845-9. PubMed ID: 9667721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peptic ulcer: changing indications for gastric resection during the last 15 years].
    Della Beffa V; Carelli-Basile A; Leli R; Fontana D
    Minerva Chir; 1994 Nov; 49(11):1065-9. PubMed ID: 7708225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit?
    Lee YT; Sung JJ; Choi CL; Chan FK; Ng EK; Ching JY; Leung WK; Chung SC
    Am J Gastroenterol; 1998 Jun; 93(6):928-31. PubMed ID: 9647021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 28. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ulcer therapy today].
    Stalder GA
    Schweiz Rundsch Med Prax; 1983 Sep; 72(37):1167-8. PubMed ID: 6138767
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antacids and gastroduodenal topical drugs].
    Raphael M
    Soins; 1988 Sep; (516):I-II. PubMed ID: 2904175
    [No Abstract]   [Full Text] [Related]  

  • 31. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
    Preiser JC
    BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
    [No Abstract]   [Full Text] [Related]  

  • 32. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology.
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():191-201. PubMed ID: 8103024
    [No Abstract]   [Full Text] [Related]  

  • 33. Innovations in peptic ulcer disease: histamine 2-receptor antagonists.
    Romankiewicz N
    J Pract Nurs; 1983; 33(8):8-9. PubMed ID: 6140313
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pro conservative long-term therapy of peptic ulcer].
    Arnold R
    Z Gastroenterol; 1984 Apr; 22(4):195-7. PubMed ID: 6145261
    [No Abstract]   [Full Text] [Related]  

  • 35. [Conservative long-term therapy of peptic ulcer--pro and con].
    Rösch W
    Z Gastroenterol; 1984 Apr; 22(4):194. PubMed ID: 6145260
    [No Abstract]   [Full Text] [Related]  

  • 36. Do we need stress ulcer prophylaxis?
    Reines HD
    Crit Care Med; 1990 Mar; 18(3):344. PubMed ID: 1968001
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of gastrectomy without vagotomy with either Roux-en-Y or Billroth II anastomosis in peptic ulcer.
    Rieu PM; Joosten HJ; Jansen JB; Lamers CB
    Hepatogastroenterology; 1994 Jun; 41(3):294-7. PubMed ID: 7959558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylaxis of stress ulcers].
    Kivilaakso E
    Duodecim; 1993; 109(3):237-42. PubMed ID: 7912180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.